Business Wire

Calvin Klein, Inc. Announces Multi-Year Collaboration with The Andy Warhol Foundation for the Visual Arts

Del

Calvin Klein, Inc., a wholly owned subsidiary of PVH Corp. (NYSE:PVH), today announced a multi-year partnership with The Andy Warhol Foundation for the Visual Arts, Inc.

Calvin Klein, Inc.’s financial commitment will support the foundation’s endowment from which it distributes grants sustaining the creation, presentation and documentation of contemporary visual art. In turn, Calvin Klein will be granted unprecedented access to the late artist’s works, including many that have not yet been published. The global partnership is effective through 2020 and will extend to licensing projects across various business lines and future activations within the CALVIN KLEIN brand portfolio.

“I am proud that through this licensing agreement with The Andy Warhol Foundation for the Visual Arts, Calvin Klein will be continuing its longstanding commitment to the celebration of American artists and their prolific work,” said Steve Shiffman, Chief Executive Officer, Calvin Klein, Inc. “I look forward to the global rollout of this partnership across multiple levels of the CALVIN KLEIN consumer experience.”

“I’ve come to realize that Warhol’s genius goes much deeper than cheerful Campbell’s Soup paintings,” said Raf Simons, Chief Creative Officer. “He captured all sides of the American experience, including sometimes its darker sides. Warhol’s art tells more truths about this country than you can find almost anywhere else.”

“Warhol’s legacy is not limited to the tremendous influence of his timeless concepts but also through the work of the foundation he established, which has become one of the pre-eminent funders of contemporary art having distributed over $275 million in grants since inception,” said Michael Dayton Hermann, Director of Licensing at the Warhol Foundation. “We are proud that Raf’s visionary work at Calvin Klein will unabashedly embrace all facets of Warhol’s work and generously contribute to the foundation’s endowment.”

The first iteration of the partnership was unveiled in September 2017, with Raf Simons’ Spring 2018 CALVIN KLEIN 205W39NYC runway show. The collection, which is available in stores in January 2018, incorporates a selection of Warhol artworks as placement screen prints. The body of work is intimately connected to the collection’s inspirations of cinema, the dream factory of Hollywood and its depictions of both an American nightmare and the all-powerful American dream. The pieces feature portraits of Warhol intimate and art collector Sandra Brant (1971) and movie star Dennis Hopper (1971), as well as Knives (1981–82), Electric Chair (1964–65), and Ambulance Disaster (1963–64) from Warhol’s Death and Disaster series. The collection also features pieces produced under license and in collaboration with Hopper Goods, a brand inspired by the life and spirit of actor, photographer, and iconoclast Dennis Hopper.

Andy Warhol’s links to fashion dated back to his first years as an artist, when his witty shoe pictures drew eyes to Vogue and Harper’s Bazaar. In the 1970s, the connection became more personal when Warhol befriended a fresh generation of New York designers that of course included Mr. Calvin Klein himself. Klein had set out to capture a new, truly American essence in his creations, and that meshed perfectly with Warhol’s own interests.

Now, 30 years after Warhol’s death, Simons is setting out to renew the relationship between the great American fashion house of CALVIN KLEIN and this greatest of American artists. Thanks to The Andy Warhol Foundation for the Visual Arts, Simons has been forging what he sees as a deep, thoroughgoing collaboration with the undying genius of Warhol, built on the creative ideals that they share. Like Warhol’s art, Simons’ designs for 2018 and beyond are committed to a fearless embrace of the place and the times that we live in.

About Calvin Klein

CALVIN KLEIN is a global lifestyle brand that exemplifies bold, progressive ideals and a seductive aesthetic. We seek to thrill and inspire our audience while using provocative imagery and striking designs to ignite the senses.

Founded in 1968 by Calvin Klein and his business partner Barry Schwartz, we have built our reputation as a leader in American fashion through our clean aesthetic and innovative designs. Global retail sales of CALVIN KLEIN brand products exceeded $8 billion in 2016 and were distributed in over 110 countries. CALVIN KLEIN employs over 10,000 associates globally. We were acquired by PVH Corp. in 2003.

About PVH Corp.

With a history going back over 135 years, PVH has excelled at growing brands and businesses with rich American heritages, becoming one of the largest apparel companies in the world. We have over 35,000 associates operating in over 40 countries and over $8 billion in annual revenues. We own the iconic CALVIN KLEIN , TOMMY HILFIGER , Van Heusen , IZOD , ARROW , Speedo *, Warner’s and Olga brands, as well as the digital-centric True & Co. intimates brand, and market a variety of goods under these and other nationally and internationally known owned and licensed brands.

*The Speedo brand is licensed for North America and the Caribbean in perpetuity from Speedo International Limited.

About The Andy Warhol Foundation for the Visual Arts, Inc.

As the preeminent American artist of the 20th Century, Andy Warhol challenged the world to see art differently. Since its founding in 1987 in accordance with Andy Warhol’s will, The Andy Warhol Foundation has established itself as among the leading funders of contemporary art in the United States having distributed over $275,000,000 in grants supporting the creation, presentation and documentation of contemporary visual arts, particularly work that is experimental, under-recognized or challenging in nature. The foundation’s ongoing efforts to protect and enhance its founder’s creative legacy ensure that Warhol’s inventive, open-minded spirit will have a profound impact on the visual arts for generations to come. Proceeds the foundation receives from licensing projects such as this contribute to the Foundation’s endowment from which it distributes grants. For more information please visit www.warholfoundation.org.

EDITORIAL CREDIT:

 

CALVIN KLEIN

 

SOCIAL MEDIA:

facebook.com/calvinklein ; calvinklein.tumblr.com ; google.com/+calvinklein ;

youtube.com/calvinklein ; twitter.com/calvinklein ; instagram.com/calvinklein ;

pinterest.com/calvinklein

snapchat: calvinklein

 

brand handle: @calvinklein

Contact information

Calvin Klein, Inc.
Alexandra Wagner, 212-292-9794
SVP, Corporate Communications
alexandrawagner@ck.com
or
Amanda Peña, 212-292-9223
Director, Corporate Communications
amandapena@ck.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom